FMNL3 and nasopharyngeal carcinoma: Positive cytoplasmic expression of FMNL3 protein (+, ++ and +++) was observed in 67.2% (80/119) of NPC patients compared with 6.9% (2/29) of NPG patients (p < 0.001) (Fig. 1 and Table 1), suggesting a major role of FMNL3 expression in NPC pathogenesis.